RELATED CONTENT
NEWS
- Japan competition for Plavix looms as prasugrel stacks up in comparative trial
- Cangrelor rises like a CHAMPION PHOENIX in third PhIII trial vs clopidogrel
- Next steps unclear as Roche's inclacumab meets Phase II endpoint in post-angioplasty study
- Vasopharm seeks brain injury drug partner on positive Phase II
COMMENT
Other Informa Comment
FEATURES
Other Informa Features

